Although blood tests exist for many pathological conditions (e.g. heart attacks and mononucleosis), the FDA has never approved a blood test to diagnose neurological conditions such as Parkinson’s disease, Alzheimer’s disease or TBI. Although these neurologic conditions are associated with specific protein breakdown products (called biomarkers), they don’t get into the body’s bloodstream